vs
BIOCRYST PHARMACEUTICALS INC（BCRX）与Playtika Holding Corp.（PLTK）财务数据对比。点击上方公司名可切换其他公司
Playtika Holding Corp.的季度营收约是BIOCRYST PHARMACEUTICALS INC的1.7倍（$678.8M vs $406.6M），BIOCRYST PHARMACEUTICALS INC净利率更高（60.5% vs -45.6%，领先106.0%），BIOCRYST PHARMACEUTICALS INC同比增速更快（209.1% vs 4.4%），BIOCRYST PHARMACEUTICALS INC自由现金流更多（$291.2M vs $275.2M），过去两年BIOCRYST PHARMACEUTICALS INC的营收复合增速更高（109.4% vs 2.1%）
BioCryst Pharmaceuticals是一家总部位于美国北卡罗来纳州达勒姆的制药企业，属于后期发展阶段的生物科技公司，聚焦于治疗罕见重症的口服药物研发。其研发的抗病毒药物帕拉米韦（商品名Rapivab）于2014年12月获得美国FDA批准，此后也陆续在日本、韩国与中国获批上市。
Playtika Holding Corp是一家专注于移动端游戏开发与发行的以色列数字娱乐企业，主打休闲社交类手游产品，在全球拥有庞大用户群体。截至2021年，该公司月活跃用户规模已经突破3500万，是行业内影响力突出的移动游戏厂商。
BCRX vs PLTK — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $406.6M | $678.8M |
| 净利润 | $245.8M | $-309.3M |
| 毛利率 | 97.7% | 72.5% |
| 营业利润率 | 64.0% | -41.4% |
| 净利率 | 60.5% | -45.6% |
| 营收同比 | 209.1% | 4.4% |
| 净利润同比 | 1017.5% | -1752.1% |
| 每股收益（稀释后） | $1.13 | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $406.6M | $678.8M | ||
| Q3 25 | $159.4M | $674.6M | ||
| Q2 25 | $163.4M | $696.0M | ||
| Q1 25 | $145.5M | $706.0M | ||
| Q4 24 | $131.5M | $650.3M | ||
| Q3 24 | $117.1M | $620.8M | ||
| Q2 24 | $109.3M | $627.0M | ||
| Q1 24 | $92.8M | $651.2M |
| Q4 25 | $245.8M | $-309.3M | ||
| Q3 25 | $12.9M | $39.1M | ||
| Q2 25 | $5.1M | $33.2M | ||
| Q1 25 | $32.0K | $30.6M | ||
| Q4 24 | $-26.8M | $-16.7M | ||
| Q3 24 | $-14.0M | $39.3M | ||
| Q2 24 | $-12.7M | $86.6M | ||
| Q1 24 | $-35.4M | $53.0M |
| Q4 25 | 97.7% | 72.5% | ||
| Q3 25 | 98.6% | 73.6% | ||
| Q2 25 | 98.3% | 71.9% | ||
| Q1 25 | 96.9% | 72.0% | ||
| Q4 24 | 95.4% | 72.5% | ||
| Q3 24 | 97.3% | 72.9% | ||
| Q2 24 | 98.4% | 73.2% | ||
| Q1 24 | 98.6% | 72.8% |
| Q4 25 | 64.0% | -41.4% | ||
| Q3 25 | 18.6% | 14.6% | ||
| Q2 25 | 18.2% | 15.8% | ||
| Q1 25 | 14.6% | 9.6% | ||
| Q4 24 | -3.4% | 8.5% | ||
| Q3 24 | 6.6% | 15.7% | ||
| Q2 24 | 8.0% | 22.4% | ||
| Q1 24 | -15.6% | 15.1% |
| Q4 25 | 60.5% | -45.6% | ||
| Q3 25 | 8.1% | 5.8% | ||
| Q2 25 | 3.1% | 4.8% | ||
| Q1 25 | 0.0% | 4.3% | ||
| Q4 24 | -20.4% | -2.6% | ||
| Q3 24 | -12.0% | 6.3% | ||
| Q2 24 | -11.6% | 13.8% | ||
| Q1 24 | -38.1% | 8.1% |
| Q4 25 | $1.13 | $-0.83 | ||
| Q3 25 | $0.06 | $0.11 | ||
| Q2 25 | $0.02 | $0.09 | ||
| Q1 25 | $0.00 | $0.08 | ||
| Q4 24 | $-0.13 | $-0.04 | ||
| Q3 24 | $-0.07 | $0.11 | ||
| Q2 24 | $-0.06 | $0.23 | ||
| Q1 24 | $-0.17 | $0.14 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $274.7M | $684.2M |
| 总债务越低越好 | — | $2.4B |
| 股东权益账面价值 | $-119.2M | $-411.4M |
| 总资产 | $514.2M | $3.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $274.7M | $684.2M | ||
| Q3 25 | $212.9M | $587.9M | ||
| Q2 25 | $260.0M | $500.9M | ||
| Q1 25 | $295.1M | $434.8M | ||
| Q4 24 | $320.9M | $565.8M | ||
| Q3 24 | $96.8M | $1.1B | ||
| Q2 24 | $78.4M | $710.3M | ||
| Q1 24 | $84.3M | $1.0B |
| Q4 25 | — | $2.4B | ||
| Q3 25 | — | $2.4B | ||
| Q2 25 | — | $2.4B | ||
| Q1 25 | — | $2.4B | ||
| Q4 24 | — | $2.4B | ||
| Q3 24 | — | $2.4B | ||
| Q2 24 | — | $2.4B | ||
| Q1 24 | — | $2.4B |
| Q4 25 | $-119.2M | $-411.4M | ||
| Q3 25 | $-387.9M | $-74.8M | ||
| Q2 25 | $-421.6M | $-87.8M | ||
| Q1 25 | $-451.9M | $-117.2M | ||
| Q4 24 | $-475.9M | $-131.1M | ||
| Q3 24 | $-468.6M | $-98.0M | ||
| Q2 24 | $-475.6M | $-112.9M | ||
| Q1 24 | $-476.2M | $-180.4M |
| Q4 25 | $514.2M | $3.7B | ||
| Q3 25 | $446.4M | $3.7B | ||
| Q2 25 | $457.2M | $3.6B | ||
| Q1 25 | $480.0M | $3.6B | ||
| Q4 24 | $490.4M | $3.6B | ||
| Q3 24 | $491.3M | $3.2B | ||
| Q2 24 | $472.4M | $3.2B | ||
| Q1 24 | $467.9M | $3.1B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $292.0M | $285.9M |
| 自由现金流经营现金流 - 资本支出 | $291.2M | $275.2M |
| 自由现金流率自由现金流/营收 | 71.6% | 40.5% |
| 资本支出强度资本支出/营收 | 0.2% | 1.6% |
| 现金转化率经营现金流/净利润 | 1.19× | — |
| 过去12个月自由现金流最近4个季度 | $344.9M | $531.4M |
8季度趋势，按日历期对齐
| Q4 25 | $292.0M | $285.9M | ||
| Q3 25 | $41.6M | $116.9M | ||
| Q2 25 | $41.3M | $146.1M | ||
| Q1 25 | $-27.5M | $18.8M | ||
| Q4 24 | $-5.2M | $153.1M | ||
| Q3 24 | $8.2M | $156.9M | ||
| Q2 24 | $-1.4M | $150.5M | ||
| Q1 24 | $-53.7M | $29.6M |
| Q4 25 | $291.2M | $275.2M | ||
| Q3 25 | $40.3M | $106.5M | ||
| Q2 25 | $41.1M | $141.3M | ||
| Q1 25 | $-27.7M | $8.4M | ||
| Q4 24 | $-5.9M | $140.3M | ||
| Q3 24 | $8.2M | $152.1M | ||
| Q2 24 | $-1.5M | $141.2M | ||
| Q1 24 | $-53.9M | $15.6M |
| Q4 25 | 71.6% | 40.5% | ||
| Q3 25 | 25.3% | 15.8% | ||
| Q2 25 | 25.2% | 20.3% | ||
| Q1 25 | -19.0% | 1.2% | ||
| Q4 24 | -4.5% | 21.6% | ||
| Q3 24 | 7.0% | 24.5% | ||
| Q2 24 | -1.4% | 22.5% | ||
| Q1 24 | -58.1% | 2.4% |
| Q4 25 | 0.2% | 1.6% | ||
| Q3 25 | 0.8% | 1.5% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 0.1% | 1.5% | ||
| Q4 24 | 0.5% | 2.0% | ||
| Q3 24 | 0.1% | 0.8% | ||
| Q2 24 | 0.1% | 1.5% | ||
| Q1 24 | 0.3% | 2.1% |
| Q4 25 | 1.19× | — | ||
| Q3 25 | 3.23× | 2.99× | ||
| Q2 25 | 8.12× | 4.40× | ||
| Q1 25 | -859.91× | 0.61× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.99× | ||
| Q2 24 | — | 1.74× | ||
| Q1 24 | — | 0.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCRX
暂无分部数据
PLTK
| Third Party Platform | $428.7M | 63% |
| Other | $158.8M | 23% |
| Asia Pacific | $52.7M | 8% |
| Other Geographic Location | $38.6M | 6% |
